ANTI-DARATUMUMAB ANTIBODY - ANVISA Registration 80134860308

Access comprehensive regulatory information for ANTI-DARATUMUMAB ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80134860308 and manufactured by MEDION DIAGNOSTICS GRIFOLS AG. The registration is held by GRIFOLS BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.